Clark NM - Search Results

1

Development and implementation of a piperacillin-tazobactam extended infusion guideline.

Heinrich LS, Tokumaru S, Clark NM, Garofalo J, Paek JL, Grim SA. Heinrich LS, et al. Among authors: clark nm. J Pharm Pract. 2011 Dec;24(6):571-6. doi: 10.1177/0897190011406984. J Pharm Pract. 2011. PMID: 21676847

2

Management of infectious complications in solid-organ transplant recipients.

Grim SA, Clark NM. Grim SA, et al. Among authors: clark nm. Clin Pharmacol Ther. 2011 Aug;90(2):333-42. doi: 10.1038/clpt.2011.90. Epub 2011 Jun 29. Clin Pharmacol Ther. 2011. PMID: 21716270 Review. No abstract available.

3

Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis.

Seroy JT, Grim SA, Reid GE, Wellington T, Clark NM. Seroy JT, et al. Among authors: clark nm. J Antimicrob Chemother. 2016 Sep;71(9):2563-8. doi: 10.1093/jac/dkw178. Epub 2016 May 30. J Antimicrob Chemother. 2016. PMID: 27246234

4

Rapid development of Acinetobacter baumannii resistance to tigecycline.

Reid GE, Grim SA, Aldeza CA, Janda WM, Clark NM. Reid GE, et al. Among authors: clark nm. Pharmacotherapy. 2007 Aug;27(8):1198-201. doi: 10.1592/phco.27.8.1198. Pharmacotherapy. 2007. PMID: 17655518

5

Limitations of current antiretroviral agents and opportunities for development.

Jain R, Clark NM, Diaz-Linares M, Grim SA. Jain R, et al. Among authors: clark nm. Curr Pharm Des. 2006;12(9):1065-74. doi: 10.2174/138161206776055813. Curr Pharm Des. 2006. PMID: 16515486 Review.

6

Update in the treatment of non-influenza respiratory virus infection in solid organ transplant recipients.

Grim SA, Reid GE, Clark NM. Grim SA, et al. Among authors: clark nm. Expert Opin Pharmacother. 2017 Jun;18(8):767-779. doi: 10.1080/14656566.2017.1322063. Epub 2017 Apr 28. Expert Opin Pharmacother. 2017. PMID: 28425766 Free PMC article. Review.

7

Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes.

Grim SA, Berger K, Teng C, Gupta S, Layden JE, Janda WM, Clark NM. Grim SA, et al. Among authors: clark nm. J Antimicrob Chemother. 2012 Mar;67(3):707-14. doi: 10.1093/jac/dkr511. Epub 2011 Dec 18. J Antimicrob Chemother. 2012. PMID: 22184469

8

Risk factors and outcomes associated with vancomycin-resistant Enterococcus infections with reduced susceptibilities to linezolid.

Santayana EM, Grim SA, Janda WM, Layden JE, Lee TA, Clark NM. Santayana EM, et al. Among authors: clark nm. Diagn Microbiol Infect Dis. 2012 Sep;74(1):39-42. doi: 10.1016/j.diagmicrobio.2012.05.025. Epub 2012 Jun 30. Diagn Microbiol Infect Dis. 2012. PMID: 22749382

9

The risk of seizures among the carbapenems: a meta-analysis.

Cannon JP, Lee TA, Clark NM, Setlak P, Grim SA. Cannon JP, et al. Among authors: clark nm. J Antimicrob Chemother. 2014 Aug;69(8):2043-55. doi: 10.1093/jac/dku111. Epub 2014 Apr 16. J Antimicrob Chemother. 2014. PMID: 24744302

10

Early intra-abdominal infections associated with orthotopic liver transplantation.

Reid GE, Grim SA, Sankary H, Benedetti E, Oberholzer J, Clark NM. Reid GE, et al. Among authors: clark nm. Transplantation. 2009 Jun 15;87(11):1706-11. doi: 10.1097/TP.0b013e3181a60338. Transplantation. 2009. PMID: 19502964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

322 results

Search Page

Filters